Aveanna Healthcare Holdings (AVAH) has received a new Buy rating, initiated by BMO Capital analyst, .
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
BMO Capital has given its Buy rating due to a combination of factors including Aveanna Healthcare Holdings’ recent financial performance and strategic initiatives. The company has seen a significant increase in its stock value, driven by successful state reimbursement rate increases and effective cost management, which have collectively reduced its leverage ratio.
Furthermore, Aveanna’s strategy to negotiate higher reimbursement rates with payers allows it to offer competitive wages to caregivers, addressing the supply-demand imbalance in the home-care sector. This approach not only attracts more caregivers but also increases patient volumes, contributing to a positive long-term EBITDA growth outlook. The company’s efforts to expand its preferred payer arrangements and its focus on value-based care arrangements further support BMO Capital’s optimistic view on its future performance.
In another report released on November 7, Barclays also maintained a Buy rating on the stock with a $9.00 price target.